company background image
TRUM.F logo

Terumo OTCPK:TRUM.F Stock Report

Last Price

US$36.72

Market Cap

US$27.6b

7D

-3.8%

1Y

38.4%

Updated

27 Mar, 2024

Data

Company Financials +

TRUM.F Stock Overview

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally.

TRUM.F fundamental analysis
Snowflake Score
Valuation1/6
Future Growth1/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Terumo Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Terumo
Historical stock prices
Current Share PriceJP¥36.72
52 Week HighJP¥39.69
52 Week LowJP¥24.96
Beta0.51
1 Month Change-5.22%
3 Month Change9.53%
1 Year Change38.41%
3 Year Change-0.13%
5 Year Change22.17%
Change since IPO119.63%

Recent News & Updates

Recent updates

Shareholder Returns

TRUM.FUS Medical EquipmentUS Market
7D-3.8%2.2%0.4%
1Y38.4%13.3%28.8%

Return vs Industry: TRUM.F exceeded the US Medical Equipment industry which returned 12% over the past year.

Return vs Market: TRUM.F exceeded the US Market which returned 29.5% over the past year.

Price Volatility

Is TRUM.F's price volatile compared to industry and market?
TRUM.F volatility
TRUM.F Average Weekly Movement5.8%
Medical Equipment Industry Average Movement7.7%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: TRUM.F has not had significant price volatility in the past 3 months.

Volatility Over Time: TRUM.F's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192130,207Shinjiro Satohttps://www.terumo.com

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts.

Terumo Corporation Fundamentals Summary

How do Terumo's earnings and revenue compare to its market cap?
TRUM.F fundamental statistics
Market capUS$27.63b
Earnings (TTM)US$654.50m
Revenue (TTM)US$5.85b

42.2x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRUM.F income statement (TTM)
RevenueJP¥885.17b
Cost of RevenueJP¥431.30b
Gross ProfitJP¥453.86b
Other ExpensesJP¥354.82b
EarningsJP¥99.04b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)66.71
Gross Margin51.27%
Net Profit Margin11.19%
Debt/Equity Ratio18.6%

How did TRUM.F perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

32%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.